What do we need to make genetic biomarker-guided treatment for renal cell carcinoma a reality?

Meta H. DIekstra, Xiaoyan Liu, Jesse J. Swen, Henk Jan Guchelaar

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalPharmacogenomics
Volume18
Issue number1
DOIs
Publication statusPublished - Jan 2017
Externally publishedYes

Keywords

  • biomarker
  • pharmacogenetics
  • renal cell carcinoma
  • SNP
  • targeted therapy

Cite this